Literature DB >> 30903092

Macular OCT-angiography parameters to predict the clinical stage of nonproliferative diabetic retinopathy: an exploratory analysis.

Tiago M Rodrigues1,2,3, João P Marques4,5,6, Mário Soares4, Sílvia Simão5, Pedro Melo4, Amélia Martins4, João Figueira4,5,6, Joaquim N Murta4,5,6, Rufino Silva4,5,6.   

Abstract

BACKGROUND: To test whether a single or a composite set of macular vascular density parameters, evaluated with optical coherence tomography angiography (OCTA), are able to predict nonproliferative diabetic retinopathy (NPDR) staging according to the gold-standard ETDRS-grading scheme.
METHODS: Prospectively defined, cross-sectional study in which macular structural and vascular parameters of diabetic eyes with nonproliferative DR (up to ETDRS Level 53) were evaluated with OCTA (Avanti RTVue-XR 100, Optovue Inc, Fremont, CA). Seven-field photographs of the fundus were taken for DR staging according to the ETDRS-grading scheme. The vessel density in the superficial and deep capillary plexus (SCP and DCP, respectively), as well as in the choriocapillaris (CC), were calculated using automated software. Univariate and multivariate ordered logistic regression models were used in the analysis. P < 0.05 was considered statistically significant.
RESULTS: We included 101 eyes from 56 subjects (mean (SD) age 62.64 (11.74) years; 57.4% were male). On univariate analysis, several OCTA parameters were found to be associated with higher ETDRS level (parafoveal SCP density: OR = 0.87 (95% CI 0.76-0.99), p = 0.039; parafoveal DCP density: OR = 0.79 (95% CI 0.72-0.87), p < 0.001; CC density: OR = 0.89 (95% CI 0.80-0.99)), p = 0.036). In the final model, while also adjusting for relevant clinical features, only parafoveal vessel density in the DCP remained as a significant predictor of NPDR ETDRS level (OR = 0.54 (95% CI 0.32-0.92), p = 0.024).
CONCLUSION: Our results suggest that parafoveal vessel density in the DCP is the parameter most robustly associated with ETDRS level. OCTA analysis may provide objective imaging biomarkers to monitor NPDR clinical progression.

Entities:  

Mesh:

Year:  2019        PMID: 30903092      PMCID: PMC7005819          DOI: 10.1038/s41433-019-0401-7

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  1 in total
  1 in total
  9 in total

1.  Three-dimensional structural and angiographic evaluation of foveal ischemia in diabetic retinopathy: method and validation.

Authors:  Bingjie Wang; Acner Camino; Shaohua Pi; Yukun Guo; Jie Wang; David Huang; Thomas S Hwang; Yali Jia
Journal:  Biomed Opt Express       Date:  2019-06-24       Impact factor: 3.732

2.  Optical Coherence Tomography Angiography Contributions in Classification of Nonproliferative Diabetic Retinopathy.

Authors:  Armin Kasumovic; Ines Matoc; Nesina Avdagic; Tarik Halimic; Bahrija Voloder; Lejla Muhamedagic; Seldjana Catovic Delic; Irena Sesar
Journal:  Acta Inform Med       Date:  2020-06

3.  Evaluation of the different thresholding strategies for quantifying choriocapillaris using optical coherence tomography angiography.

Authors:  Rita Laiginhas; Diogo Cabral; Manuel Falcão
Journal:  Quant Imaging Med Surg       Date:  2020-10

4.  Detection of the Microvascular Changes of Diabetic Retinopathy Progression Using Optical Coherence Tomography Angiography.

Authors:  Xiaogang Wang; Yongqing Han; Gang Sun; Fang Yang; Wen Liu; Jing Luo; Xing Cao; Pengyi Yin; Frank L Myers; Liang Zhou
Journal:  Transl Vis Sci Technol       Date:  2021-06-01       Impact factor: 3.283

5.  Clinical and Molecular-Genetic Insights into the Role of Oxidative Stress in Diabetic Retinopathy: Antioxidant Strategies and Future Avenues.

Authors:  Silvia M Sanz-González; José J García-Medina; Vicente Zanón-Moreno; María I López-Gálvez; David Galarreta-Mira; Lilianne Duarte; Mar Valero-Velló; Ana I Ramírez; J Fernando Arévalo; María D Pinazo-Durán
Journal:  Antioxidants (Basel)       Date:  2020-11-09

6.  Optical Coherence Tomography Angiography in Type 1 Diabetes Mellitus. Report 1: Diabetic Retinopathy.

Authors:  Marina Barraso; Aníbal Alé-Chilet; Teresa Hernández; Cristian Oliva; Irene Vinagre; Emilio Ortega; Marc Figueras-Roca; Anna Sala-Puigdollers; Cristina Esquinas; Enric Esmatjes; Alfredo Adán; Javier Zarranz-Ventura
Journal:  Transl Vis Sci Technol       Date:  2020-09-30       Impact factor: 3.283

7.  Associations between Macular OCT Angiography and Nonproliferative Diabetic Retinopathy in Young Patients with Type 1 Diabetes Mellitus.

Authors:  Nina C B B Veiby; Aida Simeunovic; Martin Heier; Cathrine Brunborg; Naila Saddique; Morten C Moe; Knut Dahl-Jørgensen; Hanna D Margeirsdottir; Goran Petrovski
Journal:  J Diabetes Res       Date:  2020-11-30       Impact factor: 4.011

8.  Retinal Vascularization Abnormalities Studied by Optical Coherence Tomography Angiography (OCTA) in Type 2 Diabetic Patients with Moderate Diabetic Retinopathy.

Authors:  Guisela Fernández-Espinosa; Ana Boned-Murillo; Elvira Orduna-Hospital; María Dolores Díaz-Barreda; Ana Sánchez-Cano; Sofía Bielsa-Alonso; Javier Acha; Isabel Pinilla
Journal:  Diagnostics (Basel)       Date:  2022-02-01

Review 9.  Optical Coherence Tomography Angiography in Diabetic Patients: A Systematic Review.

Authors:  Ana Boned-Murillo; Henar Albertos-Arranz; María Dolores Diaz-Barreda; Elvira Orduna-Hospital; Ana Sánchez-Cano; Antonio Ferreras; Nicolás Cuenca; Isabel Pinilla
Journal:  Biomedicines       Date:  2021-12-31
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.